Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies

0
140
Gilead Sciences, Inc. and EVOQ Therapeutics, Inc. announced a collaboration and licensing agreement to advance EVOQ’s proprietary technology for the treatment of rheumatoid arthritis and lupus.
[Gilead Sciences Inc.]
Full Article